Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2021-07-26 2021-06-21
Drug Identification Number 02468611 02468611
Brand name SANDOZ SAXAGLIPTIN SANDOZ SAXAGLIPTIN
Common or Proper name SANDOZ SAXAGLIPTIN SANDOZ SAXAGLIPTIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients SAXAGLIPTIN SAXAGLIPTIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30FCT CA 30FCT CA
ATC code A10BH A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-18 2021-06-18
Estimated end date 2021-07-16 2021-07-16
Actual end date 2021-07-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments